Want to join the conversation?
$PH said the US FDA has given clearance to market and sell the Indego exoskeleton, a powered orthotic device that helps paraplegics to stand and walk, for use in the US. Company intends to commercially launch the device in the US in the coming months. Indego is commercially available in Europe, having received CE Mark in Nov. 2015.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?